Pala, S. Et Al. 2015. Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study. DRUG DESIGN DEVELOPMENT AND THERAPY , vol.9 , 1761-1766.

Pala, S., Atilgan, R., Ozkan, Z. S., Kavak, S. B., Ilhan, N., Akpolat, N., ... Sapmaz, E.(2015). Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study. DRUG DESIGN DEVELOPMENT AND THERAPY , vol.9, 1761-1766.

Pala, Sehmus Et Al. "Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study," DRUG DESIGN DEVELOPMENT AND THERAPY , vol.9, 1761-1766, 2015

Pala, Sehmus Et Al. "Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study." DRUG DESIGN DEVELOPMENT AND THERAPY , vol.9, pp.1761-1766, 2015

Pala, S. Et Al. (2015) . "Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study." DRUG DESIGN DEVELOPMENT AND THERAPY , vol.9, pp.1761-1766.

@article{article, author={Sehmus Pala Et Al. }, title={Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study}, journal={DRUG DESIGN DEVELOPMENT AND THERAPY}, year=2015, pages={1761-1766} }